OTCMKTS:ELXMF Nova Eye Medical (ELXMF) Stock Price, News & Analysis $0.01 0.00 (0.00%) As of 10/9/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Nova Eye Medical Stock (OTCMKTS:ELXMF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nova Eye Medical alerts:Sign Up Key Stats Today's Range$0.0143▼$0.014350-Day Range$0.0143▼$0.014352-Week Range$0.0019▼$0.0143VolumeN/AAverage Volume75,600 shsMarket CapitalizationN/AP/E Ratio1.96Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Nova Eye Medical Limited is an Australian ophthalmic medical-device company focused on technologies for the diagnosis and treatment of eye diseases, particularly glaucoma. The company develops and commercializes laser-based and surgical solutions designed to support ophthalmologists in managing elevated intraocular pressure and other conditions affecting vision. Its product portfolio includes the iTrack family of microcatheter-based devices for minimally invasive glaucoma surgery and canaloplasty, as well as ophthalmic laser systems used in glaucoma and retinal procedures. Nova Eye Medical also offers laser platforms and related equipment intended for use by eye-care professionals in hospitals, clinics, and specialist practices. The company was formerly known as Ellex Medical Lasers and has roots in Australia’s ophthalmic technology sector. Nova Eye Medical serves international markets through a combination of direct operations and distribution partners, with products marketed to ophthalmology practices and health-care providers in regions including North America, Europe, Asia, and Australia.AI Generated. May Contain Errors. Read More Receive ELXMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nova Eye Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELXMF Stock News HeadlinesNova Eye Medical sets October date for in-person AGM and proxy votingSeptember 29, 2026 | tipranks.comNova Eye Medical Adds 45,809 Shares to ASX QuotationSeptember 21, 2026 | tipranks.comFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.October 10 at 1:00 AM | Stansberry Research (Ad)Nova Eye Medical Reports Lapse of 100,000 Unexercised OptionsSeptember 1, 2026 | theglobeandmail.comNova Eye Medical Lodges 2026 Corporate Governance Statement with ASXAugust 26, 2026 | tipranks.comNova Eye Medical Limited (ELXMF) Q4 2026 Earnings Call TranscriptAugust 4, 2026 | seekingalpha.comNova Eye Medical to Host Investor Webinar on June Quarter ResultsJuly 28, 2026 | tipranks.comNova Eye Medical Limited (ELXMF) Q3 2026 Earnings Call TranscriptMay 5, 2026 | seekingalpha.comSee More Headlines ELXMF Stock Analysis - Frequently Asked Questions How have ELXMF shares performed this year? Nova Eye Medical's stock was trading at $0.0019 at the start of the year. Since then, ELXMF stock has increased by 652.9% and is now trading at $0.0143. How do I buy shares of Nova Eye Medical? Shares of ELXMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:ELXMF CIKN/A Webwww.ellex.com Phone61 8 7074 8200FaxN/AEmployees301Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio1.96 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (OTCMKTS:ELXMF) was last updated on 10/10/2026 by MarketBeat.com Staff. From Our PartnersThis high yielding “gold annuity” is starting to move…Garrett Goggin, a 20+ year gold analyst, has called major moves before: Montage Gold up 2,567%, G2 Goldfields ...Golden Portfolio | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | SponsoredThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | SponsoredTech expert smashes iPhone with golf clubTwenty years ago, Josh Baylin told Congress the iPhone was coming, three years before it launched. A $1,500 be...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nova Eye Medical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Nova Eye Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELXMF Stock Alerts